Diabetologia
Diabetologia
0012-186X
1432-0428
Springer-Verlag
Berlin/Heidelberg


2170457
18060661
866
10.1007/s00125-007-0866-y
Article


Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men

Jocken
J. W. E.

J.Jocken@HB.Unimaas.nl

1

Goossens
G. H.

1

van Hees
A. M. J.

1

Frayn
K. N.

2

van Baak
M.

1

Stegen
J.

1

Pakbiers
M. T. W.

3

Saris
W. H. M.

1

Blaak
E. E.

1

1
Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University, Maastricht, The Netherlands 
2
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK 
3
Department of Nuclear Medicine, University Hospital Maastricht, Maastricht, The Netherlands 

5
12
2007

2
2008

51
2
320
327
29
8
2007

8
10
2007


© The Author(s) 2007

Aims/hypothesis
Obesity is characterised by increased triacylglycerol storage in adipose tissue. There is in vitro evidence for a blunted beta-adrenergically mediated lipolytic response in abdominal subcutaneous adipose tissue (SAT) of obese individuals and evidence for this at the whole-body level in vivo. We hypothesised that the beta-adrenergically mediated effect on lipolysis in abdominal SAT is also impaired in vivo in obese humans.

Methods
2
5
−1
−1
].

Results
p
−1
−1
p
−1
−1
p
−1
−1
p
 = 0.06].

Conclusions/interpretation
We demonstrated in vivo that beta-adrenergically mediated lipolytic response is impaired systematically and in abdominal SAT of obese versus lean men. This may be important in the development or maintenance of increased triacylglycerol stores and obesity.


Keywords
Adipose tissue
Arterio–venous differences
Beta-adrenergic stimulation
Catecholamines
Glycerol
In vivo
Lipolysis
Obesity
Triacylglycerol

issue-copyright-statement
© Springer-Verlag 2008




Introduction
1
2
3
4
5
6
7
2
8
]. We hypothesised that beta-adrenergically mediated lipolytic response at the whole-body and abdominal subcutaneous adipose tissue (SAT) level is impaired in vivo in obese persons. If so, this might contribute to the increased fat storage in this adipose tissue depot.
2
5
R
a
9
10
].

Methods
Participants
2
2
5
2
2
2
5
1
11
Table 1
Clinical characteristics of the participants

 
n
 = 13)
n
 = 10)


Age (years)
43 ± 3
54 ± 3

2
)
23.0 ± 0.5
a


FM (kg)
15.2 ± 0.8
a


WHR
0.91 ± 0.01
a


Systolic blood pressure (mmHg)
126 ± 3
137 ± 4

Diastolic blood pressure (mmHg)
77 ± 2
85 ± 3

HOMA-IR
1.8 ± 0.2
a




Values are mean ± SEM
a
p
 < 0.05 obese vs lean
HOMA-IR, homeostatic model assessment of insulin resistance




Experimental protocol
Pilot study
2
5
n
2
5
−1
−1
t
t
t
t
t
t
t
t
t
t
t
360 min).
Whole-body and SAT lipolysis study
2
5
−1
−1
−1
−1
n
t
t
t
t
t
t
133
12
13
].

Clinical methods
14
2
5
−1
−1
3
15
15
]. The adipose vein was kept patent by continuous saline (9 g/l NaCl) infusion at a rate of 80 ml/h. The participants rested in a supine position for the duration of the study.

Analytical methods
2
g
16
]. Packed cell volume was measured using a microcapillary system (Hirschmann Laborgeräte, Eberstadt, Germany).

Isotope enrichment
g
m
z
17
].

Calculations
The net exchange (flux) of metabolites across abdominal SAT was calculated by multiplying the arterio–venous concentration difference of metabolites by adipose tissue plasma flow. Plasma flow was calculated as ATBF×(1–packed cell volume), with packed cell volume expressed as a fraction. A positive net flux indicates net uptake from plasma, whereas a negative net flux indicates net tissue release.
The expected adipose vein enrichment, in case of no glycerol uptake, was calculated as arterialised enrichment multiplied by arterialised glycerol concentration divided by the measured adipose vein enrichment.
R
a
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ R_{a} {\left( {\mu \operatorname{mol} \,kg^{{ - 1}} \,\min ^{{ - 1}} } \right)} = \operatorname{TTR} ^{{ - 1}}  \times F $$\end{document}

F
−1
−1
).
2
5
2
5
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$
{\text{abdominal}}\,{\text{SAT}}\,{\text{total}}\,{\text{glycerol}}\,{\text{uptake = fract $   \times  $ }}{\left( {{\text{glycerol}}_{{{\text{art}}}} } \right)}{\text{ $   \times  $ ATBF}}
$$\end{document}

−1
−1
art
−1
−1
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
$$
{\text{abdominal}}\,{\text{SAT}}\,{\text{total}}\,{\text{glycerol}}\,{\text{release = abdominal}}\,{\text{SAT}}\,{\text{net}}\,{\text{glycerol}}\,{\text{flux - abdominal}}\,{\text{SAT}}\,{\text{total}}\,{\text{glycerol}}\,{\text{uptake}}$$\end{document}



Statistical analysis
t
p
 < 0.05 was considered statistically significant.


Results
Characteristics
1
2
Table 2
Circulating (arterialised) metabolite levels during baseline (fasting) and isoprenaline infusion in lean and obese participants

 
Lean
Obese

n
 = 13)
n
 = 10)
n
 = 10)
n
 = 7)


TAG (μmol/l)
701 ± 66
648 ± 64
b

a


NEFA (μmol/l)
661 ± 41
942 ± 53
638 ± 42
a


Glycerol (μmol/l)
102 ± 5
118 ± 7
106 ± 4
a


R
a
 (μmol/min)
199 ± 12
311 ± 28
220 ± 15
391 ± 30

R
a
−1
−1
]
13.1 ± 0.9
20.9 ± 1.6
b

a


Glucose (mmol/l)
5.3 ± 0.1
5.4 ± 0.1
5.5 ± 0.2
5.4 ± 0.1

Insulin (pmol/l)
50 ± 4
74 ± 6
b

a




Values are mean ± SEM
b
p
a
p
t
 test




Tracer/tracee ratio
2
5
n
1
n
2
5
Fig. 1
2
5
n
 = 3) in arterialised blood (squares) and blood draining from abdominal SAT (adipose vein; black circles). White circles, expected adipose vein enrichment. The measured adipose vein enrichment was consistently lower than the expected enrichment





Circulating metabolites
2
p
2
).
p
p
2
R
a
2
R
a
p
2
R
a
p
2
R
a
R
a
−1
−1
p
2
), suggesting a blunted lipolytic response per unit of FM in obese participants.
2
p
2
).

Abdominal SAT lipolysis
2
2
5
p
p
−1
−1
p
2
r
p
Fig. 2
a
b
2
5
p
 < 0.05 for change (Δ) from baseline obese vs lean




3
3
−1
−1
p
2
−1
−1
p
3
Table 3
Blood flow and net SAT fluxes during baseline (fasting) and isoprenaline infusion in lean and obese participants

 
Lean
Obese

n
 = 13)
n
 = 10)
n
 = 10)
n
 = 7)


−1
−1
]
2.2 ± 0.2
6.3 ± 1.2
a

3.6 ± 0.6

−1
−1
]

TAG
25 ± 8
43 ± 17
34 ± 29
113 ± 62

NEFA
−780 ± 160
−2,101 ± 371
−486 ± 101
−1,824 ± 667

Glycerol
−229 ± 49
−640 ± 148
−211 ± 51
−486 ± 128

Glucose
53 ± 49
−69 ± 151
−143 ± 96
−677 ± 632



Values are mean ± SEM
A positive net flux indicates net uptake from plasma, whereas a negative net flux indicates net tissue release
a
p
t
 test





Discussion
The present study was designed to investigate in vivo whole-body and abdominal SAT lipolysis in obese and lean men. To our knowledge, this is the first study to show in vivo that obese participants have a blunted beta-adrenergically mediated lipolytic response per unit of adipose tissue.
Methodological considerations
9
10
2
5
2
5
]glycerol were achieved in arterialised and adipose vein enrichment after 1 h and remained constant for the subsequent 5 h. Thus, our data support the use of a relatively short infusion time (1 h) for study of glycerol metabolism.

Glycerol uptake
2
5
9
10
18
]. This enzyme is responsible for the phosphorylation of glycerol into glycerol 3-phosphate, making it available for re-esterification.

Abdominal SAT lipolytic response to beta-adrenergic stimulation
2
4
5
6
7
2
8
19
22
7
4
23
2
].
24
25
26
].

Whole-body beta-adrenergically mediated lipolytic response
R
a
2
27
28
29
30
31
]. Future studies are needed to elucidate whether an increased TAG flux across SAT might contribute to the increased TAG storage in adipose tissue of obese participants.


Conclusion
The present study demonstrates in vivo that obese men have a blunted beta-adrenergically mediated lipolytic response in abdominal SAT. Therefore, a blunted lipolysis during beta-adrenergic stimulation may be an important factor in the development or maintenance of increased TAG stores and obesity.


Acknowledgements
The authors greatly appreciate the technical support of P. van der Baan and the willingness of the volunteers to participate in this study. This research was supported by a grant from the Netherlands Organization for Scientific Research (NWO/ZonMw contract no. 015.01.095) to E. E. Blaak.
Duality of interest statement
 The authors declare that there is no duality of interest associated with this manuscript.
Open Access
 This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

References
1.
Campbell
PJ

Carlson
MG

Nurjhan
N


Fat metabolism in human obesity
Am J Physiol
1994
266
E600
E605

8178981


2.
Horowitz
JF

Klein
S


Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women
Am J Physiol Endocrinol Metab
2000
278
E1144
E1152

10827018


3.
Blaak
EE

Baak
MA

Kemerink
GJ

Pakbiers
MT

Heidendal
GA

Saris
WH


Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men
Am J Physiol
1994
267
E306
E315

7915493


4.
Blaak
EE

Baak
MA

Kemerink
GJ

Pakbiers
MT

Heidendal
GA

Saris
WH


beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men
Am J Physiol
1994
267
E316
E322

7915494


5.
Bougneres
P

Stunff
CL

Pecqueur
C

Pinglier
E

Adnot
P

Ricquier
D


In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity
J Clin Invest
1997
99
2568
2573

9169485


6.
Enoksson
S

Talbot
M

Rife
F

Tamborlane
WV

Sherwin
RS

Caprio
S


Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls
Diabetes
2000
49
2149
2153
10.2337/diabetes.49.12.2149

11118019


7.
Hellstrom
L

Langin
D

Reynisdottir
S

Dauzats
M

Arner
P


Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives
Diabetologia
1996
39
921
928
10.1007/BF00403911

8858214


8.
Reynisdottir
S

Wahrenberg
H

Carlstrom
K

Rossner
S

Arner
P


Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors
Diabetologia
1994
37
428
435

8063046


9.
Kurpad
A

Khan
K

Calder
AG



Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo
Clin Sci (Lond)
1994
86
177
184

8143428


10.
Coppack
SW

Persson
M

Judd
RL

Miles
JM


Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo
Am J Physiol
1999
276
E233
E240

9950781


11.
Goossens
GH

Blaak
EE

Saris
WH

Baak
MA


Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects
J Clin Endocrinol Metab
2004
89
2690
2696
10.1210/jc.2003-032053

15181043


12.
Larsen
OA

Lassen
NA

Quaade
F


Blood flow through human adipose tissue determined with radioactive xenon
Acta Physiol Scand
1966
66
337
345

5331269


13.
Goossens
GH

Jocken
JW

Blaak
EE

Schiffers
PM

Saris
WH

Baak
MA


Endocrine role of the renin–angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation
Hypertension
2007
49
542
547
10.1161/01.HYP.0000256091.55393.92

17224474


14.
Abumrad
NN

Rabin
D

Diamond
MP

Lacy
WW


Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man
Metabolism
1981
30
936
940
10.1016/0026-0495(81)90074-3

7022111


15.
Frayn
KN

Coppack
SW

Humphreys
SM

Whyte
PL


Metabolic characteristics of human adipose tissue in vivo
Clin Sci (Lond)
1989
76
509
516

2721118


16.
Matthews
DR

Hosker
JP

Rudenski
AS

Naylor
BA

Treacher
DF

Turner
RC


Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
Diabetologia
1985
28
412
419
10.1007/BF00280883

3899825


17.
Blaak
EE

Wagenmakers
AJ

Glatz
JF



Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle
Am J Physiol Endocrinol Metab
2000
279
E146
E154

10893334


18.
Tan
GD

Debard
C

Tiraby
C



A “futile cycle” induced by thiazolidinediones in human adipose tissue?
Nat Med
2003
9
811
812
10.1038/nm0703-811

12835685


19.
Reynisdottir
S

Ellerfeldt
K

Wahrenberg
H

Lithell
H

Arner
P


Multiple lipolysis defects in the insulin resistance (metabolic) syndrome
J Clin Invest
1994
93
2590
2599

8200997


20.
Large
V

Reynisdottir
S

Langin
D



Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects
J Lipid Res
1999
40
2059
2066

10553009


21.
Lofgren
P

Hoffstedt
J

Ryden
M



Major gender differences in the lipolytic capacity of abdominal subcutaneous fat cells in obesity observed before and after long-term weight reduction
J Clin Endocrinol Metab
2002
87
764
771
10.1210/jc.87.2.764

11836318


22.
Schiffelers
SL

Saris
WH

Boomsma
F

Baak
MA


Beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men
J Clin Endocrinol Metab
2001
86
2191
2199
10.1210/jc.86.5.2191

11344226


23.
Karpe
F

Tan
GD


Adipose tissue function in the insulin-resistance syndrome
Biochem Soc Trans
2005
33
1045
1048
10.1042/BST20051045

16246042


24.
Borsheim
E

Lonnroth
P

Knardahl
S

Jansson
PA


No difference in the lipolytic response to beta-adrenoceptor stimulation in situ but a delayed increase in adipose tissue blood flow in moderately obese compared with lean men in the postexercise period
Metabolism
2000
49
579
587
10.1016/S0026-0495(00)80031-1

10831166


25.
Schiffelers
SL

Akkermans
JA

Saris
WH

Blaak
EE


Lipolytic and nutritive blood flow response to beta-adrenoceptor stimulation in situ in subcutaneous abdominal adipose tissue in obese men
Int J Obes Relat Metab Disord
2003
27
227
231
10.1038/sj.ijo.802230

12587003


26.
Sjostrand
M

Gudbjornsdottir
S

Holmang
A

Strindberg
L

Ekberg
K

Lonnroth
P


Measurements of interstitial muscle glycerol in normal and insulin-resistant subjects
J Clin Endocrinol Metab
2002
87
2206
2211
10.1210/jc.87.5.2206

11994365


27.
Havel
RJ

Kane
JP

Balasse
EO

Segel
N

Basso
LV


Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans
J Clin Invest
1970
49
2017
2035

5475985


28.
Bulow
J

Simonsen
L

Wiggins
D



Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose
J Lipid Res
1999
40
2034
2043

10553007


29.
Samra
JS

Simpson
EJ

Clark
ML



Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism
Am J Physiol
1996
271
E834
E839

8944669


30.
Yukht
A

Davis
RC

Ong
JM

Ranganathan
G

Kern
PA


Regulation of lipoprotein lipase translation by epinephrine in 3T3-L1 cells. Importance of the 3′ untranslated region
J Clin Invest
1995
96
2438
2444

7593632


31.
Ong
JM

Saffari
B

Simsolo
RB

Kern
PA


Epinephrine inhibits lipoprotein lipase gene expression in rat adipocytes through multiple steps in posttranscriptional processing
Mol Endocrinol
1992
6
61
69
10.1210/me.6.1.61

1738372



Abbreviations
ATBF
adipose tissue blood flow


FFM
fat free mass


FM
fat mass


R
a

glycerol rate of appearance


SAT
abdominal subcutaneous adipose tissue


TAG
triacylglycerol


TTR
tracer/tracee ratio






